Limba
|
Gambogenic Acid, identified from Gamboge, is an inhibitor of the FGFRsignaling pathway in non-small-cell lung cancer (NSCLC) and exhibits anti-tumor effects. Gambogenic acid acts is also an effective inhibitor of EZH2that specifically and covalently binds to Cys668 within the EZH2-SET domain, and triggers EZH2 ubiquitination.
Price | 3.819,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Gambogenic Acid, identified from Gamboge, is an inhibitor of the FGFRsignaling pathway in non-small-cell lung cancer (NSCLC) and exhibits anti-tumor effects. Gambogenic acid acts is also an effective inhibitor of EZH2that specifically and covalently binds to Cys668 within the EZH2-SET domain, and triggers EZH2 ubiquitination. |